Ameriprise
ETON icon

Ameriprise’s Eton Pharmaceutcials ETON Stock Holding History

Ameriprise’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-161,928
Closed -$709K – 3884
2023
Q4 		$709K Sell
161,928
-24,634
-13% -$98.8K ﹤0.01% 3323
2023
Q3 		$778K Buy
+186,562
New +$720K ﹤0.01% 3247

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise's ETON Position: Q1 2024 in Review

Ameriprise sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 161,928 shares — an estimated $709K sold.

Ameriprise first reported a position in ETON in Q3 2023 and held it in 2 quarters. The position peaked at $778K in Q3 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • Ameriprise reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • Ameriprise sold 161,928 Eton Pharmaceutcials shares in Q1 2024, an estimated $709K.
  • Ameriprise first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 2 quarters.
  • Ameriprise's Eton Pharmaceutcials position peaked at $778K in Q3 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.